SHARE
COPY LINK

HEALTH

Europe warned to prepare for mpox as Pakistan reports first case

Health authorities warned Friday that Europe must be ready for more cases of a deadly strain of mpox that has killed hundreds of people in the Democratic Republic of Congo.

Europe warned to prepare for mpox as Pakistan reports first case
A health worker takes a sample at the Mpox treatment centre of the Nyiragongo general referral hospital, north of the town of Goma in the Democratic Republic of Congo. Photo: GUERCHOM NDEBO/AFP.

The World Health Organisation urged pharmaceutical firms to ramp up vaccine production and China said it would screen travellers for the disease after the first cases of the more deadly strain to be recorded outside Africa were announced in Sweden and Pakistan.

France’s Prime Minister Gabriel Attal said his country was on the “highest alert” and would implement “new recommendations” for travellers to risk areas.

Mpox is caused by a virus transmitted to humans by animals but can also spread human-to-human through close physical contact.

It causes fever, muscular aches and large boil-like skin lesions.

The WHO on Wednesday declared the rapid spread of the new Clade 1b strain an international public health emergency — the agency’s highest alert.

This follows the spread of the more deadly mpox from Democratic Republic of Congo (DRC) to other African countries.

READ ALSO: Sweden reports first case of deadly mpox strain outside Africa

“We do need the manufacturers to really scale up so that we’ve got access to many, many more vaccines,” WHO spokeswoman Margaret Harris told reporters.

The WHO is asking countries with vaccine stockpiles to donate them to countries with outbreaks.

Harris said mpox was “particularly dangerous for those with a weak immune system, so people who maybe have HIV or are malnourished”, and was also dangerous for small children.

The United States has said it will donate 50,000 doses of an mpox vaccine to DRC and Attal said France would also send vaccines to risk countries.

Danish drugmaker Bavarian Nordic said Thursday it would be ready to make up to 10 million doses of its mpox vaccine by 2025 but that it needed contracts to start production.

The Stockholm-based European Centre for Disease Prevention and Control (ECDC) said the overall risk in Europe was “low”. But it warned that “effective surveillance, laboratory testing, epidemiological investigation and contact tracing capacities will be vital to detecting cases.”

“Due to the close links between Europe and Africa, we must be prepared for more imported clade I cases,” ECDC director Pamela Rendi-Wagner said in a statement.

Hundreds killed in DRC

The virus has swept across DRC, killing 548 people so far this year, the government said Thursday.

Nigeria has recorded 39 mpox cases this year, but no deaths, according to its health authorities. Previously unaffected countries such as Burundi, Kenya, Rwanda and Uganda have reported outbreaks, according to the Africa Centres for Disease Control and Prevention.

Sweden’s Public Health Agency announced Thursday it had registered a case of Clade 1b.

The patient was infected during a visit to “the part of Africa where there is a major outbreak of mpox Clade 1”, epidemiologist Magnus Gisslen said in a statement.

The mpox strain in the Pakistan case was not immediately known, the country’s health ministry said in a statement.

It said the patient, a 34-year-old man, had “come from a Gulf country”.

China announced it would begin screening people and goods entering the country for mpox over the next six months.

People arriving from countries where outbreaks have occurred, who have been in contact with mpox cases or display symptoms should “declare to customs when entering the country”, China’s customs administration said.

Vehicles, containers and items from areas with mpox cases should be sanitised, it added in a statement.

Vaccination drive

Mpox has two subtypes: the more virulent and deadlier Clade 1, endemic in the Congo Basin in central Africa; and Clade 2, endemic in West Africa.

A worldwide outbreak beginning in 2022 involving the Clade 2b subclade caused some 140 deaths out of about 90,000 cases, mostly affecting gay and bisexual men.

France reported 107 cases of the milder mpox variant between January 1 and June 30 this year.

The WHO’s European regional office in Copenhagen said the Sweden case was “a clear reflection of the interconnectedness of our world”.

But it added: “Travel restrictions and border closures don’t work and should be avoided.”

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.
For members

HEALTH

Who should get vaccinated against mpox in Austria?

Mpox is expected to spread further, and the WHO has declared a "public health emergency". Who in Austria is advised to get vaccinated against it?

Who should get vaccinated against mpox in Austria?

Recently, the World Health Organisation (WHO) warned that Europe is likely to experience more imported cases of the new, more dangerous strain of mpox.

WHO has asked vaccine manufacturers to increase production due to the outbreak, which started in Africa and has now spread to other parts of the world.

 
The request for more vaccines started after the recent discovery of a more dangerous virus strain called ‘1b,’ which was identified in Sweden and Pakistan.

The situation is not new; there was also a major mpox outbreak in 2022, which led to around 200 deaths. However, the recent discovery of a more dangerous strain, along with rising cases and the virus spreading further, has led the WHO to declare a “public health emergency of international concern.” 

What is mpox?

Mpox, or Affenpocken in German, is an infectious viral disease. It is caused by a virus initially spread to humans by animals, but it can also be transmitted between people through direct contact.

Common symptoms include muscular aches and pains, large lesions and boils, and fever.

Mpox was initially discovered in monkeys in a Danish laboratory in 1958. The first human case was identified in a child in the Democratic Republic of the Congo in 1970.

READ MORE: Europe warned to prepare for mpox as Pakistan reports first case

Who should get vaccinated in Austria?

The National Vaccination Committee (NIG) in Austria currently only recommends vaccination for specific risk groups, such as the following: 

  • Individuals with high-risk behaviour (e.g., those with frequent changing sexual contacts, particularly men with same-sex partners)
  • Staff in specialised laboratories (e.g., those handling samples from individuals infected with mpox or those working with the virus itself)
  • Healthcare workers with very high exposure risk (e.g., those working in designated departments, outpatient clinics, or organisations for diagnosing and treating mpox infections).

Additionally, vaccination can also be considered for travellers who have extensive and prolonged contact with local populations, such as employees of aid organisations in affected countries.

Where can you get the vaccine?

The vaccine is still not available on the open market in Austria and is only offered free of charge at selected vaccination centres in the federal states.

You can check the offers in your state HERE.

How many doses are needed?

The recommended vaccination schedule is currently two doses with an interval of at least 28 days. 

However, if someone is already infected with the virus, a single dose is recommended, and it should be administered within four days of the first close contact.

If a person already has symptoms, the vaccine is not recommended.

READ ALSO: WHO warns more mpox expected in Europe over the coming days or weeks

SHOW COMMENTS